To evaluate the in vivo effects of Prdx2 knockdown, we used a subcutaneous xenotransplant tumor model by injecting the CD133+ cells sorted from HCT116-shPrdx2 or HCT116-shCont into female BALB/c-nu mice. The gene discussed is PROM1; the disease is neoplasm.